Holland Capital Invests in Curess

Amsterdam, June 20th, 2024 – Holland Capital participates in Curess, a leading organization in youth care focused on systemic family support. Through the collaboration with Holland Capital, further growth and development can be achieved.

Systemic Family Support

Curess offers specialized ambulatory youth care (such as intensive systemic guidance, ambulatory emergency help, perspective research, and co-parenting investigations) and focuses on strengthening families through practical and directly applicable assistance. Curess operates without waiting lists and can scale its operations up and down quickly, to deliver the desired care swiftly and with high quality. The organization achieves this by applying self-developed software that supports core processes (such as planning) and thus reduces administrative pressure.

Strategic Parntership

With this strategic partnership, Curess has found a partner to achieve its ambitious strategic goals.

Eddy de Bruin, CEO of Curess, states: “With the support of Holland Capital, we can realize our ambitions and help even more young people and families. With their expertise and resources, we are better equipped to significantly increase our impact in youth care. We are committed to providing the necessary support to families to learn to live together better, without waiting lists, through our dedicated professionals.”

Margot Engels, Healthcare Partner at Holland Capital, adds: “We are proud to add Curess to our portfolio. Curess provides crucial support to families in an innovative way, and we look forward to working together on their growth ambitions and further professionalization of their services. Our shared vision is to provide the best possible care and support.”

About Curess

With over 200 registered professionals, Curess offers specialized ambulatory youth care to young people and families to ensure they can live together better. By utilizing personal and innovative methods, Curess strives for a safe and supportive environment for children and their families. Curess is active in the regions of Twente, Midden-IJssel, Oost-Veluwe, Noord-Veluwe, Achterhoek, and Zuid-Drenthe

About Holland Capital

Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and Agrifood-Tech sectors. They understand the dynamics and opportunities, and have an extensive network in these sectors.

 The participation in Curess fits within Holland Capital’s strategy to invest in companies that contribute to societal challenges and create value for society. With this investment, Holland Capital takes an important step in further strengthening its portfolio within the healthcare sector.

Holland Capital invests in nanotech company Kriya Materials

Holland Capital invests in nanotech company Kriya Materials

Amsterdam August 5, 2022 – Holland Capital is investing in Kriya Materials (Kriya), a leading developer of advanced nanotechnology-based custom coating solutions. The funding will be used to accelerate international expansion.  Advanced coating solutions Kriya...

Holland Capital invests in Health IT company Open HealthHub

Holland Capital invests in Health IT company Open HealthHub

Amsterdam, 26 July 2022 – Holland Capital is investing in Open HealthHub, a digital platform that allows healthcare providers and patients to exchange medical data safely and securely. It will also reduce the administrative burden on healthcare providers. The...

Mauritskliniek intends to join Corius

Mauritskliniek intends to join Corius

Amsterdam, 21 July 2022 – Our portfolio company Mauritskliniek intends to join Corius. Mauritskliniek provides healthcare services in dermatology, varicose veins, proctology, skin therapy and medical-cosmetic care. The Mauritskliniek is located in Amsterdam, The...

Holland Capital realizes successful exit of Humeca to i4hi

Holland Capital realizes successful exit of Humeca to i4hi Borne / Amsterdam, 5 July 2022 – Investment company Holland Capital realizes a successful exit of Humeca to fellow investor i4hi. Humeca is a leading supplier of innovative products in the field of advanced...

AMP Group acquires Omega Logistics business operations

AMP Group acquires Omega Logistics business operations Houten, 23 May 2022 - Our portfolio company AMP is taking its second step in the buy-and-build strategy with the acquisition of the business activities of Omega Logistics, a medical logistics provider. Through...

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411

 

Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120

Contact
info@hollandcapital.nl